2004-001220-20: Efficacy and Safety of PEG-Intron plus Rebetol in Subjects with Chronic Hepatitis C Genotype 1 Non Responder to Pegasys |
|
|
| Completed | 3/4 | 200 | Europe, RoW | Pegintron, Rebetol, SCH 54031, SCH 18908, Injection*, Capsule, hard, PegIntron, Rebetol | Integrated Therapeutics Group, Incorporated - a subsidiary of Schering-Plough, Integrated Therapeutics Group, Incorporated- a subsidiary of Schering Plough, SCHERING-PLOUGH | Chronic Hepatitis C, Genotype 1 | | | | |
